Overall, given the enormity of the obesity epidemic and associated health problems and the lack of understanding of, and effective pharmacological therapies for, eating disorders such as anorexia nervosa, there is a strong justification for further studies that involve chronic manipulation of RXFP3 signaling to assess feeding, metabolism, and body weight. This evidence concerns the gene RXFP3 and obesity due to melanocortin 4 receptor deficiency.